InsidersTradesSigma
Discover the full record of transactions filed by Sullivan Lara, Chairman & CEO. Director active across 1 company, notably Pyxis Oncology, Inc.. Cumulatively, 2 filings have been logged. Activity tracked since 31 March 2022. The latest transaction was filed on 14 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Lara Sullivan is the Chief Executive Officer of Pyxis Oncology, Inc. In this role, she leads the company in its efforts to develop innovative oncology treatments. Lara brings extensive experience in the biotechnology sector, contributing to optimizing the company's operations.